FDA Approves Emergent's Inhalation Anthrax Treatment
Emergent BioSolutions Inc. will receive $7 million from the federal government after winning U.S. Food and Drug Administration approval for a first-of-its-kind anthrax treatment, the company announced Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article